The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis.
暂无分享,去创建一个
[1] G. Raymond,et al. Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines. , 2015, Molecular genetics and metabolism.
[2] M. Abdelnoor,et al. Age-dependent penetrance among females with X-linked adrenoleukodystrophy. , 2015, Brain : a journal of neurology.
[3] A. Moser,et al. A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3. , 2015, Human molecular genetics.
[4] A. Moser,et al. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy. , 2015, Molecular genetics and metabolism.
[5] B. Poll-The,et al. Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study , 2015, Journal of Inherited Metabolic Disease.
[6] M. Engelen,et al. Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy , 2014, Neurology.
[7] H. Werner,et al. Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice , 2014, PloS one.
[8] Yong Duan,et al. Exome sequencing identifies mutations in ABCD1 and DACH2 in two brothers with a distinct phenotype , 2014, BMC Medical Genetics.
[9] S. Kahraman,et al. Successful haematopoietic stem cell transplantation in 44 children from healthy siblings conceived after preimplantation HLA matching. , 2014, Reproductive biomedicine online.
[10] B. Poll-The,et al. X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment , 2014, Current Neurology and Neuroscience Reports.
[11] S. Hewson,et al. Late-onset Zellweger spectrum disorder caused by PEX6 mutations mimicking X-linked adrenoleukodystrophy. , 2014, Pediatric neurology.
[12] R. Wanders,et al. Structure-Function Analysis of Peroxisomal ATP-binding Cassette Transporters Using Chimeric Dimers* , 2014, The Journal of Biological Chemistry.
[13] Zhiye Chen,et al. Adult cerebral adrenoleukodystrophy and Addison's disease in a female carrier. , 2014, Gene.
[14] H. Waterham,et al. A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids. , 2014, Biochimica et biophysica acta.
[15] R. Wanders,et al. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. , 2014, Brain : a journal of neurology.
[16] F. Eichler,et al. Pathophysiology of X-linked adrenoleukodystrophy☆ , 2014, Biochimie.
[17] P. Schestatsky,et al. Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics , 2014, Orphanet Journal of Rare Diseases.
[18] H. Stockinger,et al. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes , 2013, Human molecular genetics.
[19] A. Moser,et al. Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible. , 2014, Molecular genetics and metabolism.
[20] K. Claes,et al. Dealing with pseudogenes in molecular diagnostics in the next-generation sequencing era. , 2014, Methods in molecular biology.
[21] K. Xia,et al. Exome sequencing released a case of X-linked adrenoleukodystrophy mimicking recessive hereditary spastic paraplegia. , 2013, European journal of medical genetics.
[22] D. Matern,et al. Newborn screening for lysosomal storage disorders and other neuronopathic conditions. , 2013, Developmental disabilities research reviews.
[23] C. Wiesinger,et al. Impaired Very Long-chain Acyl-CoA β-Oxidation in Human X-linked Adrenoleukodystrophy Fibroblasts Is a Direct Consequence of ABCD1 Transporter Dysfunction* , 2013, The Journal of Biological Chemistry.
[24] Rodrigo Lopez,et al. Analysis Tool Web Services from the EMBL-EBI , 2013, Nucleic Acids Res..
[25] M. Abdelnoor,et al. Adrenoleukodystrophy in Norway: high rate of de novo mutations and age-dependent penetrance. , 2013, Pediatric neurology.
[26] F. Lan,et al. Familial Skewed X Chromosome Inactivation in Adrenoleukodystrophy Manifesting Heterozygotes from a Chinese Pedigree , 2013, PloS one.
[27] N. Shimozawa,et al. A Novel Double Mutation in the ABCD1 Gene in a Patient with X-linked Adrenoleukodystrophy: Analysis of the Stability and Function of the Mutant ABCD1 Protein. , 2013, JIMD reports.
[28] S. Cederbaum,et al. Peanut consumption increases levels of plasma very long chain fatty acids in humans. , 2012, Molecular genetics and metabolism.
[29] M. Morita,et al. Peroxisomal ABC transporters: structure, function and role in disease. , 2012, Biochimica et Biophysica Acta.
[30] S. Kemp,et al. See Blockindiscussions, Blockinstats, Blockinand Blockinauthor Blockinprofiles Blockinfor Blockinthis Blockinpublication X-linked Blockinadrenoleukodystrophy: Blockinclinical, Metabolic, Blockingenetic Blockinand Blockinpathophysiological Aspects Article Blockin Blockinin Blockin Blockinbiochimica B , 2022 .
[31] V. D. De Jesús,et al. Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[32] B. Poll-The,et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management , 2012, Orphanet Journal of Rare Diseases.
[33] C. Kim,et al. Mutations, Clinical Findings and Survival Estimates in South American Patients with X-Linked Adrenoleukodystrophy , 2012, PloS one.
[34] A. Moser,et al. Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy. , 2012, Molecular genetics and metabolism.
[35] G. Raymond,et al. Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated. , 2012, Molecular genetics and metabolism.
[36] B. Castellotti,et al. Preferential expression of mutant ABCD1 allele is common in adrenoleukodystrophy female carriers but unrelated to clinical symptoms , 2012, Orphanet Journal of Rare Diseases.
[37] A. Sabbagh,et al. CD1 Gene Polymorphisms and Phenotypic Variability in X-Linked Adrenoleukodystrophy , 2012, PloS one.
[38] D. Avramopoulos,et al. SOD2 as a potential modifier of X-linked adrenoleukodystrophy clinical phenotypes , 2012, Journal of Neurology.
[39] H. Waterham,et al. X‐linked adrenomyeloneuropathy due to a novel missense mutation in the ABCD1 start codon presenting as demyelinating neuropathy , 2011, Journal of the peripheral nervous system : JPNS.
[40] A. Moser,et al. X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism. , 2011, Molecular genetics and metabolism.
[41] Simon C. Potter,et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.
[42] S. Baldwin,et al. Conservation of targeting but divergence in function and quality control of peroxisomal ABC transporters: an analysis using cross-kingdom expression. , 2011, The Biochemical journal.
[43] X. Bao,et al. [Association of genetic polymorphisms in methionine metabolism genes with X-linked adrenoleukodystrophy]. , 2011, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.
[44] S. Ferdinandusse,et al. Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene , 2011, Orphanet journal of rare diseases.
[45] J. Tolar,et al. Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison’s disease improves survival and neurological outcomes , 2011, European Journal of Pediatrics.
[46] E. Génin,et al. Substrate Specificity Overlap and Interaction between Adrenoleukodystrophy Protein (ALDP/ABCD1) and Adrenoleukodystrophy-related Protein (ALDRP/ABCD2)* , 2011, The Journal of Biological Chemistry.
[47] Jian Zeng,et al. A rapid and sensitive protocol for prenatal molecular diagnosis of X-linked adrenoleukodystrophy. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[48] H. Waterham,et al. Mutations in PEX10 are a cause of autosomal recessive ataxia , 2010, Annals of neurology.
[49] T. Matsukawa,et al. Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes , 2010, neurogenetics.
[50] P. Stankiewicz,et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. , 2010, The New England journal of medicine.
[51] C. Vargas,et al. X-linked adrenoleukodystrophy: Clinical course and minimal incidence in South Brazil , 2010, Brain and Development.
[52] R. Wanders,et al. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy , 2010, EMBO molecular medicine.
[53] P. Aubourg,et al. Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X‐Linked Adrenoleukodystrophy , 2009, Brain pathology.
[54] Manfred Schmidt,et al. Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.
[55] A. Moser,et al. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. , 2009, Molecular genetics and metabolism.
[56] M. Weller,et al. Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample , 2009, Journal of Neurology.
[57] F. Eichler,et al. Case records of the Massachusetts General Hospital. Case 1-2009. A 57-year-old man with progressive cognitive decline. , 2009, The New England journal of medicine.
[58] A. Holzinger,et al. X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype. , 2008, Biochemical and biophysical research communications.
[59] H. Waterham,et al. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl–CoA esters , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] C. Giménez,et al. Pregnancy outcome after preimplantation genetic diagnosis in an affected couple with X-linked adrenoleukodystrophy. , 2008, Fertility and sterility.
[61] F. Galán,et al. Preimplantation genetic diagnosis of X-linked adrenoleukodystrophy with gender determination using multiple displacement amplification. , 2007, Fertility and sterility.
[62] F. Wouters,et al. Live Cell FRET Microscopy , 2007, Journal of Biological Chemistry.
[63] H. Bernheimer,et al. Diagnosis of X-linked adrenoleukodystrophy in blood leukocytes. , 2007, Clinical biochemistry.
[64] Yuehua Zhang,et al. [Prenatal diagnosis of X-linked adrenoleukodystrophy]. , 2007, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.
[65] P. Traubner,et al. Adrenoleukodystrophy--a new mutation identified. , 2007, Bratislavske lekarske listy.
[66] J. Gärtner,et al. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. , 2006, Biochimica et biophysica acta.
[67] K. Fliessbach,et al. The cystathionine beta‐synthase variant c.844_845ins68 protects against CNS demyelination in X‐linked adrenoleukodystrophy , 2006, Human mutation.
[68] R. Wanders,et al. Omega-oxidation of very long-chain fatty acids in human liver microsomes. Implications for X-linked adrenoleukodystrophy. , 2006, The Journal of biological chemistry.
[69] K. Fliessbach,et al. Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy , 2006, Neurology.
[70] Stephan Lorenzen,et al. Function of the PEX19-binding Site of Human Adrenoleukodystrophy Protein as Targeting Motif in Man and Yeast , 2005, Journal of Biological Chemistry.
[71] A. Moser,et al. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. , 2005, Human molecular genetics.
[72] C. Camps,et al. X‐linked adrenoleukodystrophy in Spain. Identification of 26 novel mutations in the ABCD1 gene in 80 patients. Improvement of genetic counseling in 162 relative females , 2005, Clinical genetics.
[73] H. Moser,et al. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. , 2005, The Journal of pediatrics.
[74] H. Moser. Adrenoleukodystrophy: phenotypic variability and implications for therapy , 1992, Journal of Inherited Metabolic Disease.
[75] J. Mandel,et al. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. , 2004, Human molecular genetics.
[76] Carla P. Guimarães,et al. Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo. , 2004, Biochimica et biophysica acta.
[77] H. Moser,et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. , 2004, Blood.
[78] J. Pevsner,et al. X-Linked Adrenoleukodystrophy: Genes, Mutations, and Phenotypes , 2004, Neurochemical Research.
[79] E. Bertini,et al. X-linked adrenoleukodystrophy: first report of the Italian Study Group , 1998, The Italian Journal of Neurological Sciences.
[80] P. Vreken,et al. X-linked adrenoleukodystrophy: Improved prenatal diagnosis using both biochemical and immunological methods , 1998, Journal of Inherited Metabolic Disease.
[81] S. Rechitsky,et al. Preimplantation genetic diagnosis with HLA matching. , 2004, Reproductive biomedicine online.
[82] A. Munnich,et al. Single cell co-amplification of polymorphic markers for the indirect preimplantation genetic diagnosis of hemophilia A, X-linked adrenoleukodystrophy, X-linked hydrocephalus and incontinentia pigmenti loci on Xq28 , 2004, Human Genetics.
[83] R. Wanders,et al. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders , 2003, Brain and Development.
[84] R. Wanders,et al. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. , 2003, Molecular genetics and metabolism.
[85] T. Klockgether,et al. Genetic variations and humoral immune responses to myelin oligodendroglia glycoprotein in adult phenotypes of X-linked adrenoleukodystrophy , 2003, Journal of Neuroimmunology.
[86] M. Wichers,et al. Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation , 2002, Annals of neurology.
[87] S. Tsuji,et al. Epidemiology of X-linked adrenoleukodystrophy in Japan , 2002, Journal of Human Genetics.
[88] T. Amachi,et al. ATP Binding/Hydrolysis by and Phosphorylation of Peroxisomal ATP-binding Cassette Proteins PMP70 (ABCD3) and Adrenoleukodystrophy Protein (ABCD1)* , 2002, The Journal of Biological Chemistry.
[89] H. Moser,et al. Cerebral X‐linked adrenoleukodystrophy in a girl with Xq27‐Ter deletion , 2002, Annals of neurology.
[90] Carla P. Guimarães,et al. Molecular characterization of 21 X-ALD Portuguese families: identification of eight novel mutations in the ABCD1 gene. , 2002, Molecular genetics and metabolism.
[91] G. O'neill,et al. ABCD1 translation–initiator mutation demonstrates genotype–phenotype correlation for AMN , 2001, Neurology.
[92] H. Moser,et al. ABCD1 mutations and the X‐linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations , 2001, Human mutation.
[93] Carla P. Guimarães,et al. Characterisation of two mutations in the ABCD1 gene leading to low levels of normal ALDP , 2001, Human Genetics.
[94] J. Zeman,et al. Eight novel ABCD1 gene mutations and three polymorphisms in patients with X‐linked adrenoleukodystrophy: The first polymorphism causing an amino acid exchange , 2001, Human mutation.
[95] H. Moser,et al. Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening , 2001, Annals of neurology.
[96] H. Moser,et al. Evolution of phenotypes in adult male patients with X‐linked adrenoleukodystrophy , 2001, Annals of neurology.
[97] G. Uziel,et al. Myelin oligodendrocyte glycoprotein (MOG) polymorphisms and adrenoleukodystrophy , 2000, Journal of Neuroimmunology.
[98] J. Berger,et al. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy. , 2000, Human molecular genetics.
[99] R. Benarous,et al. Homo- and Heterodimerization of Peroxisomal ATP-binding Cassette Half-transporters* , 1999, The Journal of Biological Chemistry.
[100] A. Holzinger,et al. The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression. , 1999, European journal of biochemistry.
[101] A. Holzinger,et al. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. , 1999, Human molecular genetics.
[102] Andreas Holzinger,et al. Prenatal diagnosis of X‐linked adrenoleukodystrophy combining biochemical, immunocytochemical and DNA analyses , 1999, Prenatal diagnosis.
[103] H. Moser,et al. Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. , 1999, Molecular genetics and metabolism.
[104] H. Moser,et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls , 1999, Annals of neurology.
[105] A. Moser,et al. Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy , 1998, Nature Medicine.
[106] A. Poulos,et al. X-linked adrenoleukodystrophy: the Australasian experience. , 1998, American journal of medical genetics.
[107] J. Mandel,et al. Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines. , 1998, European journal of cell biology.
[108] A. Moser,et al. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins. , 1998, Human molecular genetics.
[109] J. Gärtner,et al. Leukodystrophy incidence in Germany. , 1997, American journal of medical genetics.
[110] E. Eichler,et al. Interchromosomal duplications of the adrenoleukodystrophy locus: a phenomenon of pericentromeric plasticity. , 1997, Human molecular genetics.
[111] K. Smith,et al. Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis , 1997, Journal of Neuroimmunology.
[112] J. Mandel,et al. Adrénoleucodystrophie liée à l'X , 2007 .
[113] F. Hanefeld,et al. Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype , 1996, Annals of neurology.
[114] A. Roscher,et al. Association of X-linked adrenoleukodystrophy with HLA DRB1 alleles. , 1995, Biochemical and biophysical research communications.
[115] H. Moser,et al. Tumor necrosis factor-α and X-linked adrenoleukodystrophy , 1995, Journal of Neuroimmunology.
[116] R. Schutgens,et al. A misdiagnosis of X‐linked adrenoleucodystrophy in cultured chorionic villus cells by the measurement of very long chain fatty acids , 1995 .
[117] I. Faé,et al. X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. , 1994, Biochemical and biophysical research communications.
[118] G. Weverling,et al. Predominance of the adrenomyeloneuropathy phenotype of X‐linked adrenoleukody strophy in the Netherlands , 1994, Neurology.
[119] A. Poulos,et al. Pitfalls in the prenatal diagnosis of peroxisomal β‐oxidation defects by chorionic villus sampling , 1994, Prenatal diagnosis.
[120] D. Housman,et al. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. , 1994, American journal of medical genetics.
[121] T. Hashimoto,et al. Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis. , 1994, American journal of human genetics.
[122] E. Watkiss,et al. Is skewed X inactivation responsible for symptoms in female carriers for adrenoleucodystrophy? , 1993, Journal of medical genetics.
[123] R. Wanders,et al. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. , 1993, Clinical chemistry.
[124] Jean Mosser,et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters , 1993, Nature.
[125] N. Baumann,et al. Adrenoleukodystrophy in France: an epidemiological study. , 1993, Neuroepidemiology.
[126] A. H. Handyside,et al. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification , 1990, Nature.
[127] H. Moser,et al. Adrenoleukodystrophy , 1998, Neurology.
[128] B. Migeon,et al. Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.